BCAX Stock Summary and Trading Ideas (Bicara Therapeutics | NASDAQ:BCAX)

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

What symbol and exchange does Bicara Therapeutics shares trade?

Bicara Therapeutics trades on the NASDAQ stock market under the symbol BCAX.

What is Bicara Therapeutics stock price doing today?

As of March 13, 2026, BCAX stock price declined to $19.19 with 329,547 million shares trading.

What is Bicara Therapeutics's Beta?

BCAX has a beta of 1.86, meaning it tends to be more sensitive to market movements. BCAX has a correlation of 0.14 to the broad based SPY ETF.

How much is Bicara Therapeutics worth?

BCAX has a market cap of $1.05 billion. This is considered a Small Cap stock.

What are the top ETFs holding Bicara Therapeutics?

The top ETF exchange traded funds that BCAX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.

Is Bicara Therapeutics (BCAX) a good investment?

BCAX has outperformed the market in the last year with a price return of +43.7% while the SPY ETF gained +21.4%. BCAX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +3.8% and +14.4%, respectively, while the SPY returned -2.6% and -3.5%, respectively.

What are the support and resistance levels for Bicara Therapeutics (BCAX)?

BCAX support price is $18.17 and resistance is $20.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCAX shares will trade within this expected range on the day.